Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03150043 · ClinicalTrials.gov registry record · NA
Continuous Non-Invasive Measurement of Hemoglobin During Parturition
A NA study, sponsored by The University of Texas Medical Branch, Galveston.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
NCT03150043 is a NA study that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 65 participants.
The verdict
NCT03150043, a NA study, has completed, sponsored by The University of Texas Medical Branch, Galveston.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
Study Summary
A non-invasive hemoglobin monitor will be used during cesarean delivery and the values obtained will be compared to values obtained from traditional blood draw.
Interventions
- DEVICE Masimo Rainbow Pulse CO-oximeter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2017-05-10 |
| Est. Completion | 2018-05-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03150043
The ClinicalTrials.gov registry entry for NCT03150043 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Masimo Rainbow Pulse CO-oximeter is the first listed.
NCT03150043 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03150043 about?
NCT03150043 is a clinical study titled "Continuous Non-Invasive Measurement of Hemoglobin During Parturition". A non-invasive hemoglobin monitor will be used during cesarean delivery and the values obtained will be compared to values obtained from traditional blood draw.
What is the current status of trial NCT03150043?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2017-05-10. Estimated completion is 2018-05-09.
What interventions are being tested in trial NCT03150043?
The interventions under investigation include: Masimo Rainbow Pulse CO-oximeter (DEVICE).
Who is sponsoring clinical trial NCT03150043?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.